Graft System for Abdominal Aortic Aneurysm

A bifurcated prosthetic graft made from polyester material is designed to be implanted in an artery weakened by an abdominal aortic aneurysm (AAA) and prevent it from ballooning. Called the Ancure Endograft System, it has been granted premarket approval by the U.S. Food and drug Administration (FDA).

Conventional treatments for AAA involve the surgical replacements of the damaged portion of the aorta. After making an abdominal incision, the surgeon clamps off the aorta and removes the aneurysm. Average recovery for the patient is 47 days. In contrast, surgery is not required with the Ancure graft. A catheter delivers the graft to the aneurysm site, where it is inserted into an artery in the groin. Hooks attached to the arterial wall secure the graft. The patient can go home as early as three days after the procedure, with full recovery in an average of 11 days.

The Ancure graft is the product of Guidant Corp. (Indianapolis, IN, USA). "We are extremely pleased about beginning the full commercial release of our Ancure System,” said Beverly Huss, president of endovascular solutions at Guidant.




Related Links:
Guidant